Ovarian cancer: Screening, treatment, and follow-up

JAMA

Volumn 273, Issue 6, 1995, Pages 491-497

  Seltzer, V ^a   Batson, J L ^a   Drukker, B H ^a   Gillespie, B W ^a   Gossfeld, L M ^a   Grigsby, P W ^a   Harvey, H A ^a   Hendricks, C B ^a   Hummel, S ^a   Makuch, R W ^a   Monaco, G P ^a   Parham, G P ^a   Sawyers, C L ^a   West, R J ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER THERAPY; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; MORBIDITY; MORTALITY; OVARIECTOMY; OVARY CANCER; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; CONSENSUS DEVELOPMENT; ECHOGRAPHY; MASS SCREENING; MULTIMODALITY CANCER THERAPY; OVARY TUMOR;

CA-125 ANTIGEN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASS SCREENING; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; ULTRASONOGRAPHY;

MLCS; MLOWN;

EID: 0029639032     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.273.6.491     Document Type: Conference Paper

References (0)